Literature DB >> 7504950

Inhibition of the activity of protein tyrosine phosphate 1C by its SH2 domains.

R Townley1, S H Shen, D Banville, C Ramachandran.   

Abstract

Full-length protein tyrosine phosphatase 1C (PTP1C), the catalytic domain of PTP1C (delta PTP1C), and the N-terminal SH2 domain truncated PTP1C (delta NPTP1C) were overexpressed in Escherichia coli and purified to near homogeneity. Various phosphorylated states of the synthetic phosphotyrosyl peptide TRDIYETDYYRK (IRP), corresponding to the major insulin receptor autophosphorylation sites, were used as substrates for the PTPs. There was no indication for selective dephosphorylation of any of the three phosphotyrosyl residues from the triphosphotyrosyl IRP. Kinetic studies were carried out using all seven different phosphotyrosyl IRPs. Saturation kinetics were observed for PTP1C using the triphosphotyrosyl IRP only. In contrast, for delta PTP1C, saturation was achieved for all seven phosphotyrosyl IRPs. The best substrate for delta PTP1C was the triphosphotyrosyl IRP possessing a Km of approximately 1.6 microM, about 3-4-fold lower than either the mono- or diphosphotyrosyl IRPs. However, in contrast to delta PTP1C, PTP1C had a 22-fold lower affinity for triphosphotyrosyl IRP. Furthermore, deletion of a single N-terminal SH2 domain increased the affinity of the enzyme for the triphosphotyrosyl IRP to a value similar to that obtained with delta PTP1C. The pH optima for all three enzyme constructs were very similar and could not account for the observed change in substrate affinity between the three enzymes. These results suggest that the SH2 domain of PTP1C exerts an inhibitory effect on its PTP activity.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7504950     DOI: 10.1021/bi00212a006

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  20 in total

1.  BCR/ABL inhibition by an escort/phosphatase fusion protein.

Authors:  Y M Lim; S Wong; G Lau; O N Witte; J Colicelli
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-24       Impact factor: 11.205

2.  Structural determinants of SHP-2 function and specificity in Xenopus mesoderm induction.

Authors:  A M O'Reilly; B G Neel
Journal:  Mol Cell Biol       Date:  1998-01       Impact factor: 4.272

3.  A deletion mutation in the SH2-N domain of Shp-2 severely suppresses hematopoietic cell development.

Authors:  C K Qu; Z Q Shi; R Shen; F Y Tsai; S H Orkin; G S Feng
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

Review 4.  Regulation of signaling by protein-tyrosine phosphatases: potential roles in the nervous system.

Authors:  C O Arregui; J Balsamo; J Lilien
Journal:  Neurochem Res       Date:  2000-01       Impact factor: 3.996

5.  Identification of a cytoplasmic, phorbol ester-inducible isoform of protein tyrosine phosphatase epsilon.

Authors:  A Elson; P Leder
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-19       Impact factor: 11.205

6.  Recruitment of tyrosine phosphatase HCP by the killer cell inhibitor receptor.

Authors:  D N Burshtyn; A M Scharenberg; N Wagtmann; S Rajagopalan; K Berrada; T Yi; J P Kinet; E O Long
Journal:  Immunity       Date:  1996-01       Impact factor: 31.745

Review 7.  SHP-1 and SHP-2 in T cells: two phosphatases functioning at many levels.

Authors:  Ulrike Lorenz
Journal:  Immunol Rev       Date:  2009-03       Impact factor: 12.988

8.  [Difluro(phosphono)methyl]phenylalanine-containing peptide inhibitors of protein tyrosine phosphatases.

Authors:  S Desmarais; R W Friesen; R Zamboni; C Ramachandran
Journal:  Biochem J       Date:  1999-01-15       Impact factor: 3.857

Review 9.  Phosphatase regulation of immunoreceptor signaling in T cells, B cells and mast cells.

Authors:  Yacine Bounab; Andrew Getahun; John C Cambier; Marc Daëron
Journal:  Curr Opin Immunol       Date:  2013-05-15       Impact factor: 7.486

10.  Differential functions of the two Src homology 2 domains in protein tyrosine phosphatase SH-PTP1.

Authors:  D Pei; J Wang; C T Walsh
Journal:  Proc Natl Acad Sci U S A       Date:  1996-02-06       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.